BIO-RAD LABORATORIES, INC.·4

Nov 14, 4:33 PM ET

RAMALINGAM AJIT 4

4 · BIO-RAD LABORATORIES, INC. · Filed Nov 14, 2022

Insider Transaction Report

Form 4
Period: 2022-11-10
RAMALINGAM AJIT
SVP, Chief Accounting Officer
Transactions
  • Sale

    Bio-Rad A Common Stock

    2022-11-10$421.70/sh267$112,594112.381 total
  • Sale

    Bio-Rad A Common Stock

    2022-11-10$422.28/sh112$47,2950.381 total
  • Sale

    Bio-Rad A Common Stock

    2022-11-10$423.61/sh0.381$1610 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $421.47 to $421.94, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]Includes 13.884 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES